Mario Theliard
General Practice · West Palm Beach, FLNPI 1669804720
Payments from drug & device makers
Across 128 payments — averaging $22.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$665
- Janssen Products, LP$569
- Johnson & Johnson$530
- Viiv Healthcare Company$410
- Lilly USA, LLC$241
- Merck$116
- plus $342 from 10 others
What the payments were for
- Food & beverage$2,52688%
- Education$34712%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 27 | $665 |
| Janssen Products, LP | 6 | $569 |
| Johnson & Johnson(2 entities) | 34 | $530 |
| Viiv Healthcare Company | 25 | $410 |
| Lilly USA, LLC | 10 | $241 |
| Merck | 7 | $116 |
| Exact Sciences | 3 | $72 |
| GSK | 3 | $57 |
| Amgen | 3 | $53 |
| Novo Nordisk | 3 | $48 |
| AbbVie | 2 | $33 |
| Sanofi Pasteur Inc. | 1 | $17 |
| Hologic Sales And Service, LLC | 1 | $16 |
| Boehringer Ingelheim | 1 | $16 |
| Cranial Technologies, Inc | 1 | $15 |
| Theratechnologies Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,874 in reported general payments places this provider in the 90th percentile of 6,901 general practice providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 52 | $234,668 |
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 49 | $188,786 |
| TivicayDolutegravir Sodium | 37 | $80,563 |
| DovatoDolutegravir Sodium/Lamivudine | 23 | $64,708 |
| PrezcobixDarunavir/Cobicistat | 25 | $58,280 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 11 | $43,091 |
| DescovyEmtricitabine/Tenofov Alafenam | 14 | $31,978 |
| JardianceEmpagliflozin | 16 | $19,870 |
| MounjaroTirzepatide | 11 | $17,977 |
| SynthroidLevothyroxine Sodium | 11 | $722 |
| Atorvastatin Calcium | 76 | $668 |
| Gabapentin | 49 | $627 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $434 |
| Nifedipine ErNifedipine | 15 | $297 |
| Duloxetine Hcl | 12 | $277 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Genvoya, Descovy | $665 | $263,85574 claims |
| Janssen Products, LPSymtuza | $569 | $234,66852 claims |
| Viiv Healthcare CompanyTivicay, Dovato | $410 | $145,27160 claims |
| Johnson & JohnsonPrezcobix | $530 | $58,28025 claims |
| Boehringer IngelheimJardiance | $16 | $19,87016 claims |
| Lilly USA, LLCMounjaro | $241 | $17,97711 claims |
| AbbVieSynthroid | $33 | $72211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,901 general practice providers in Florida.
Other general practice in West Palm Beach
- Jose CardonaMiami$71M
- Lawrence GalitzMiami Gardens$42.5M
- Armando AcevedoMiami$15.2M
- Jorge AmayaMiami$14.2M
- Frank AlvarezHialeah$13.6M
- Hector RodriguezMiami$12.8M
- Eddie ArmasSouth Miami$12.4M
- Idalia AcostaMiami$11.4M
- Lilia Rodriguez AblesMiami$10.7M
- Jorge Monroy AvellaOcoee$10.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.